Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 28, 2002
Extramedullary hematopoiesis in the endometriumRosalia M Valeri, Nada Ibrahim, Michael T SheaffEndocrinology, Diabetes & Metabolism Case Reports|July 12, 2016
IgG4-related hypophysitis presenting as diabetes insipidus with tubulo-interstital nephritis and mediastinal lymphadenopathyRayna Patel, Waheed Mustafa, Michael T Sheaff, et al.Cancer Research and Treatment|January 24, 2014
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challengesMelissa M Phillips, Michael T Sheaff, Peter W SzlosarekNDT Plus|May 19, 2015
Rapamycin-induced remission of Kaposi's sarcoma is not associated with expansion of cytotoxic T-lymphocyte subsetsStephen B Walsh, Shaun A Summers, Peter L Amlot, et al.Journal of the American Academy of Dermatology|January 31, 2006
Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control seriesCatherine A Harwood, Charlotte M Proby, Jane M McGregor, et al.International Journal of Cancer|August 8, 2007
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancerDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Cancer|December 6, 2006
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trialsDean A Fennell, Amit Parmar, Jonathan Shamash, et al.Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaJustin Stebbing, Thomas Powles, Kirsty McPherson, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Pageof 2